MetaCap

Nexentis Technologies Inc. (NXTS)

NASDAQ: NXTSIndustrialsAgricultural ChemicalsUSD

1.58-0.12 (-7.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NXTS stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$367.15
52-week range
1.55 – 119.00
Day range
1.55 – 1.74
Volume / Avg
7.08K / 83.05K
Beta
—

52-week range

$1.55$119.00

NXTS stock today

Shares of Nexentis Technologies (NXTS) finished lower on Nov 20 at $1.58, a drop of 7.06% or $0.12 per share, versus the S&P 500's 3.70% decline. Trading was light, with 7.08K shares changing hands, about 9% of the average daily volume. Shares are 98.7% below their 52-week high of $119.00 and 1.9% above the 52-week low of $1.55, near the bottom of the past year's range.

Nexentis Technologies has posted a net loss over the last twelve months (EPS of -$367.15), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Nexentis Technologies

Company profile

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc.

Industry
Agricultural Chemicals
CEO
Mr. David Palach
Headquarters
Ness Ziona, NY
Employees
7

Financial highlights

Full financials

Nexentis Technologies reported a net loss of $4.0 million, compared with a loss of $5.2 million a year earlier. Diluted earnings per share came in at -$8.61.

Nexentis Technologies annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue—$210.00K$263.44K$394.00K$438.14K
Growth—-20.29%-33.14%-10.07%+88.63%
Net income$-4.00M$-5.19M$-6.52M$-5.74M$-4.82M
EPS (diluted)$-8.61$-27.74$-5.43$10.85$-2.06

Earnings

Earnings history
Last reported (Sep/2026)
Nov 16, 2026
EPS actual vs est.
$-0.33 vs —

NXTS news

All NXTS news

Nexentis Technologies peers

Industrials sector
NXTS peer companies
CompanyPrice% ChgMarket capCompare
UANCVR Partners LP95.09-0.88%—vs NXTS
ICLICL Group Ltd.4.08-1.45%—vs NXTS
SNESSenesTech Inc.0.69+6.15%$4.71Mvs NXTS
EVGNEvogene Ltd0.3162+1.02%$5.71Mvs NXTS
FRTTFort Technology Inc.0.47-9.79%$7.14Mvs NXTS
BIOXBioceres Crop Solutions Corp.0.173-5.41%$11.04Mvs NXTS
AVDAmerican Vanguard Corporation0.68-1.48%$20.10Mvs NXTS
CBUSCibus Inc. Class A1.21-1.63%$92.73Mvs NXTS

Indexes, lists and sector

Nexentis Technologies stock FAQ

What is Nexentis Technologies's stock price today?

NXTS last traded at $1.58 as of Nov 20, 4:00 PM EST, down 7.06% on the day. Prices are delayed at least 15 minutes.

Does Nexentis Technologies pay a dividend?

No. Nexentis Technologies does not currently pay a regular cash dividend.

Who is Nexentis Technologies's CEO?

Mr. David Palach is the chief executive officer of Nexentis Technologies Inc., which has about 7 employees.

Has NXTS ever split its stock?

Yes. The most recent NXTS stock split was a 1-for-5 split on Nov 9, 2026.

What is the NXTS 52-week high?

The 52-week high for NXTS is $119.00 and the 52-week low is $1.55. The stock is currently 98.7% below its high.

Compare NXTS